arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Apyx Medical Corp

APYX
$4.00 ▼ -0.16 (-3.73%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Apyx Medical Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $164.4M
Dividend Yield
Revenue Growth 9.9%
Op. Margin -12.2%
ROIC -12.7%
FCF / Share $-0.22
Trailing P/E
Price / Book 11.5x
FCF Yield
Debt / Equity 2.58
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$52.84M
↑ +9.9%
Net Income Profit after all expenses
$-11.21M
↑ +52.2%
Operating Margin Operating profit as % of sales
-12.2%
↑ +68.9% 14th
FCF / Share Free cash flow per share
$-0.22
↑ +58.0%
Long-Term Debt Long-term obligations
$37.50M
— 0.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
11
Returns
11
Financial Health
27
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters